Related Experiment Videos

Membrane-associated proteins of adriamycin sensitive and resistant murine leukemic P388 cells

International Journal of Peptide and Protein Research
|April 1, 1986
PubMed

Insights

Researchers developed an adriamycin-resistant cell line (P388/R84) from mouse leukemia P388 cells. This resistance is linked to significant changes in specific cell surface proteins, particularly those of 160 and 100 kd.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Adriamycin (doxorubicin) is a key chemotherapy agent.
  • Drug resistance in cancer cells is a major clinical challenge.
  • Understanding molecular mechanisms of drug resistance is crucial for developing new therapies.

Purpose of the Study:

  • To isolate and characterize an adriamycin-resistant mouse leukemia P388 cell line.
  • To investigate changes in cell surface proteins associated with adriamycin resistance.

Main Methods:

  • Serial cultivation of P388 cells in increasing concentrations of adriamycin.
  • Radiolabeling of sensitive and resistant cells (125I and 35S methionine).
  • Electrophoresis to analyze protein fractions.
  • Concanavalin A affinity chromatography to study surface proteins.

Main Results:

  • An 84-fold adriamycin-resistant subline (P388/R84) was successfully established.
  • Significant alterations in protein profiles were observed, including increased 160 and 100 kd proteins.
  • Differential changes in 30, 45, and 60 kd proteins were noted depending on the labeling method.
  • Confirmation of surface protein alterations using concanavalin A.

Conclusions:

  • Adriamycin resistance in P388 cells is associated with distinct changes in cell surface protein expression.
  • The identified protein alterations may contribute to the resistant phenotype.
  • Findings align with previous observations of protein changes in anthracycline-resistant cells.

Related Concept Videos